POSTEXCITATORY INHIBITION AFTER TRANSCRANIAL MAGNETIC STIMULATION OF THE MOTOR CORTEX IN PATIENTS WITH DRUG-INDUCED PARKINSONISM AND IN HEALTHY-INDIVIDUALS
H. Masur et al., POSTEXCITATORY INHIBITION AFTER TRANSCRANIAL MAGNETIC STIMULATION OF THE MOTOR CORTEX IN PATIENTS WITH DRUG-INDUCED PARKINSONISM AND IN HEALTHY-INDIVIDUALS, International clinical psychopharmacology, 13(2), 1998, pp. 79-82
The duration of the postexcitatory inhibition after transcranial magne
tic stimulation was investigated in 16 patients with drug-induced park
insonism and in 20 healthy control individuals. In the patients, the c
hlorpromazine-equivalent of the neuroleptic medication was determined,
and the severity of the drug-induced parkinsonism was measured using
the Simpson-Angus Scale score. Group comparison (U-test) revealed a si
gnificant shorter postexcitatory inhibition in patients than in contro
l individuals. Regression analyses showed a negative correlation betwe
en the Simpson-Angus scale score and the duration of the postexcitator
y inhibition. The correlation only reached significance for a group of
patients who received at least one butyrophenone derivate. No clear-c
ut relation was found between the chlorpromazine equivalent and the po
stexcitatory inhibition. These results indicate that drug-induced park
insonism shares features of genuine Parkinson's disease. Furthermore,
it seems possible to assess the extrapyramidal side effect of butyroph
enone derivates, but not for other neuroleptic drugs, by means of the
method described. (C) 1998 Rapid Science Ltd.